DMAC Earnings

Quarterly EPS
$-0.13
Q2 2024
$-0.15
Q3 2024
$-0.18
Q4 2024
$-0.18
Q1 2025
$-0.18
Q2 2025
$-0.17
Q3 2025
$-0.17
Q4 2025
$-0.19
Q1 2026
Latest RevenueN/A
Latest Net Income-10042000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.190-10042000-5.6%
Q4 2025-$0.170-8740000+5.6%
Q3 2025-$0.170-8620000-13.3%
Q2 2025-$0.180-7699000-38.5%
Q1 2025-$0.180-7707000-28.6%
Q4 2024-$0.180-7900000-38.5%
Q3 2024-$0.150-6274000-25.0%
Q2 2024-$0.130-5119000+18.8%
Q1 2024-$0.140-5151000
Q4 2023-$0.130-5161000
Q3 2023-$0.120-4471000
Q2 2023-$0.160-4477000
DiaMedica Therapeutics (DMAC) — Earnings